Skip to main content
Sino Biological Inc. logo

Sino Biological Inc. — Investor Relations & Filings

Ticker · 301047 ISIN · CNE100004Q23 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 485 across all filing types
Latest filing 2025-09-05 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301047

About Sino Biological Inc.

https://www.sinobiological.com

Sino Biological Inc. is a global provider of biological reagents and contract research services, specializing in recombinant protein and antibody technologies. The company maintains an extensive catalog of off-the-shelf products, including thousands of recombinant proteins, cytokines, viral antigens, and monoclonal antibodies. These resources support diverse applications in drug discovery, diagnostic development, and basic life science research. Beyond its product portfolio, the company offers comprehensive CRO services such as custom protein expression, antibody development, and biological testing. Utilizing high-throughput mammalian and insect cell expression platforms, Sino Biological provides scalable solutions for the pharmaceutical and biotechnology sectors. The organization is particularly noted for its rapid reagent development in response to emerging infectious diseases and its integrated approach to supporting the global research community.

Recent filings

Filing Released Lang Actions
关于控股股东部分股份质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder of the company. It details the number of shares pledged, the proportion of total shares, the pledge period, and the pledgee. It also clarifies that there is no risk of forced liquidation and that the pledge does not affect company operations or governance. The document is short (1451 characters) and is an announcement of a specific shareholder transaction rather than a financial report or management discussion. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about share pledge information and does not fit into more specific categories like Major Shareholding Notification (MRQ) because it concerns share pledge, not ownership threshold changes, nor is it a share issue or capital change (SHA).
2025-09-05 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2025 Half-Year Report Summary' (半年度报告摘要) for Beijing Sinobiological Technology Co., Ltd. It contains detailed financial data such as revenue, net profit, earnings per share, total assets, and shareholder information for the half-year period. The presence of comprehensive financial metrics and accounting data indicates this is a financial report for a period shorter than a full fiscal year. The document length is 3059 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-26 Chinese
关于2025年半年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from Beijing Yiqiao Shenzhou Technology Co., Ltd. regarding the 2025 semi-annual profit distribution plan. It includes details about the profit distribution proposal, the board and supervisory meetings approving it, and the planned cash dividend per share. The document does not contain full financial statements or comprehensive financial analysis but focuses on the dividend distribution plan and related approvals. The document length is 1339 characters, which is relatively short and typical for an announcement rather than a full report. It is not a full interim or annual report, nor is it a regulatory certification or a voting result announcement. The content fits best with a Notice of Dividend Amount (DIV) as it announces the dividend amount, payment basis, and conditions for approval and implementation.
2025-08-26 Chinese
2025年半年度募集资金存放、管理与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the storage, management, and usage of funds raised by the company during the half-year period of 2025. It includes specific financial figures about the amount raised, usage of funds, balances, investment projects, and compliance with regulatory rules related to fundraising. The presence of terms like "募集资金存放、管理与使用情况的专项报告" (special report on raised funds storage, management, and usage), references to regulatory rules on fundraising, and detailed financial data about fundraising usage indicate this is a specialized report on fundraising activities. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is substantive and not merely an announcement or certification, so it is not RPA or RNS. Therefore, the correct classification is CAP with high confidence.
2025-08-26 Chinese
2025年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "北京义翘神州科技股份有限公司 2025 年半年度报告全文" which translates to "Beijing Sino Biological Technology Co., Ltd. 2025 Semi-Annual Report Full Text." It contains detailed financial data, management discussion and analysis, business overview, financial indicators, and other comprehensive information typical of a semi-annual or interim report. The report covers the period from January 1, 2025 to June 30, 2025, which is a half-year period. It includes actual financial statements, management analysis, and detailed business and financial performance data. The document length is 15,000 characters, indicating it is a full report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-26 Chinese
关于召开2025年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice about convening the 2025 first extraordinary general meeting (临时股东大会) of Beijing Yiqiao Shenzhou Technology Co., Ltd. It includes information about the meeting date, voting methods (onsite and online), registration procedures, agenda items, and attachments such as proxy forms and voting instructions. There is no financial data or report content, but rather a formal announcement and instructions for shareholders to participate in the meeting and vote on proposals. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings. The document length (5657 characters) and content confirm it is not a brief announcement or a full report but a detailed meeting notice and proxy information.
2025-08-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.